The U.S. dental bone grafts and substitutes market size was estimated at USD 285 million in 2025 and is predicted to increase from USD 307.23 million in 2026 to approximately USD 603.99 million by 2035, expanding at a CAGR of 7.8% from 2026 to 2035. A surge in dental implant procedures, an increasing geriatric population, a shift towards cosmetic dentistry, increasing oral health awareness, rising demand for minimally invasive techniques, and expanding medical tourism are promoting the market growth.
The U.S. dental bone grafts and substitutes refer to the materials implanted into jawbone defects to replace, regenerate, or augment lost bone tissue. These products help in new bone formation as well as provide structural support for periodontal repair, dental implants, and various reconstructive procedures. They also help in socket preservation, sinus lift, ridge augmentation, and reconstruction.
The graph represents a comparison between the dental problems in adults and children across the U.S. for the year 2025. It indicates that there will be a rise in dental problems, which will drive the demand for effective and safe treatment options. This, in turn, will increase the adoption of dental grafts and substitutes for the effective management and treatment of dental problems in the U.S., which will ultimately promote the market growth.
By material type, the allografts segment accounted for the highest revenue share of 36% of the U.S. dental bone grafts and substitutes market in 2025, driven by their widespread availability. Their consistent quality also increased their use in dental implant placement and socket preservation. They also offered good osteoconductive properties, which increased their demand.
By product form type, the granules/particles segment held a major revenue share of 48% of the U.S. dental bone grafts and substitutes market in 2025, driven by their easy handling and adaptability to irregular bone defects. They also helped in offering predicted bone regeneration outcomes. They were also preferred for dental implants, sinus lifts, and socket preservation.
By application type, the dental implant placement segment contributed the biggest revenue share of 42% of the U.S. dental bone grafts and substitutes market in 2025, due to growth in the demand for permanent tooth replacement. The increased incidence of periodontal disease also increased the demand. The better functionality and durability also increased their acceptance rates.
By end user, the dental clinics segment held the largest revenue share of 62% of the U.S. dental bone grafts and substitutes market in 2025, driven by the high volume of dental procedures. They were also preferred for routine restorative and other cosmetic dental treatments. Their rapid expansion and advanced technologies also increased their use.
By distribution channel type, the direct sales segment led the U.S. dental bone grafts and substitutes market with a 46% share in 2025, driven by its robust relationships with dental clinics. They also offered direct sales of specialized bone graft products, which increased their demand. Their faster feedback and timely product availability also increased their use.
The U.S. dental bone grafts and substitutes market held a notable share in 2025 and is expected to show considerable growth during the predicted time, due to increasing incidences of tooth loss. The rise in the geriatric population and advancements in dental healthcare infrastructure also increase the adoption of various dental bone grafts and substitutes. Furthermore, growing healthcare investments are also driving their innovations, which are enhancing the market growth.
Geistlich Pharma North America dominated the market with its Geistlich Bio-Oss and Geistlich Bio-Oss Collagen, where ZimVie Inc. was its closest competitor, which provided Puros Allograft, RegenerOss Xenograft, and RegenaVate DBM Putty. Dentsply Sirona Inc. also sustained its position by providing Mineralized bone allograft, Symbios Allograft Particulate, and OSSIX Bone, where Envista Holdings Corporation also contributed to the market growth with its creos xeno. gain, creos allo. gain, and Hydroxyapatite synthetic alternatives.
By Material Type
By Product Form
By Application
By End User
By Distribution Channel
